Literature DB >> 7547638

Patterns of loss of heterozygosity at loci from chromosome arm 13q suggests a possible involvement of BRCA2 in sporadic breast tumors.

F Kerangueven1, F Allione, T Noguchi, J Adélaïde, H Sobol, J Jacquemier, D Birnbaum.   

Abstract

Loss of heterozygosity (LOH) at loci from chromosome 13 is frequently observed in breast cancer. Chromosome 13 contains at least two cancer genes, the well-characterized RB1 gene located at 13q14 and the breast cancer-susceptibility gene, BRCA2, recently localized to 13q12. To investigate the possible involvement of BRCA2 in sporadic breast tumors, we looked at LOH at eight microsatellite (CA)n markers distributed along chromosome 13 in a panel of 59 primary breast carcinomas. We show that some LOH does not include the RB1 locus and is associated with the BRCA2 gene region.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7547638     DOI: 10.1002/gcc.2870130410

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  8 in total

1.  A somatic truncating mutation in BRCA2 in a sporadic breast tumor.

Authors:  B H Weber; M Brohm; I Stec; J Backe; H Caffier
Journal:  Am J Hum Genet       Date:  1996-10       Impact factor: 11.025

2.  Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions.

Authors:  Brian J Miller; Daolong Wang; Ralf Krahe; Fred A Wright
Journal:  Am J Hum Genet       Date:  2003-09-16       Impact factor: 11.025

3.  Prognostic value of loss of heterozygosity at BRCA2 in human breast carcinoma.

Authors:  I Bièche; C Noguès; S Rivoilan; A Khodja; A Latil; R Lidereau
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

4.  Allelic loss at chromosome 13q12-q13 is associated with poor prognosis in familial and sporadic breast cancer.

Authors:  J van den Berg; O Johannsson; S Håkansson; H Olsson; A Borg
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

5.  Frequent allelic losses at 11q24.1-q25 in young women with breast cancer: association with poor survival.

Authors:  M Gentile; K Olsen; M Dufmats; S Wingren
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

6.  Association of allelic losses at 3p25.1, 13q12, or 17p13.3 with poor prognosis in breast cancers with lymph node metastasis.

Authors:  S Haga; M Emi; A Hirano; Y Utada; T Kajiwara; F Akiyama; G Sakamoto; K Takahashi; T Tada; F Kasumi; Y Miki; Y Nakamura
Journal:  Jpn J Cancer Res       Date:  2001-11

7.  Absence of methylation of CpG dinucleotides within the promoter of the breast cancer susceptibility gene BRCA2 in normal tissues and in breast and ovarian cancers.

Authors:  N Collins; R Wooster; M R Stratton
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  Chromosome alterations in breast carcinomas: frequent involvement of DNA losses including chromosomes 4q and 21q.

Authors:  A Schwendel; F Richard; H Langreck; O Kaufmann; H Lage; K J Winzer; I Petersen; M Dietel
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.